The Paradox of LDL Cholesterol and Hyperresponder Phenotype

Jeff Bullock: I know people like Nick Norwitz and Dave Feldman and Ron Kraus, who we're part of an editorial on lean mass hyper responder phenotype. And then we actually published a study from our Faster cohort on their LDL cholesterol. So what do I get so many questions about this? He says it's hard to imagine that this isolated increase in LDL is harmful when every other biomarker and indicator of health is in the normal range. But again, given the, you know, the paradigm around LDL cholesterol, it's hard not to be a little worried about it.

Play episode from 38:13

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app